make minor forecast earn chang increas target price
mark market multipl retain outperform rate
believ novozym return mid-high singl digit structur growth
support hygien launch corn inocul uptak share gain
energy/household oil price remain elev estim oil
novozym grow core busi growth
new product pipelin believ market gain comfort return
higher growth share rerat histor higher level price-to-earnings
grow confid hygien launch launch novel odor elimin
enzym begun ariel wash product philippin
promot materi use last fresh even sweat sell point
pleas benefit clearli commun given
impli old/oth product dont combat odour properli creat clear
differenti product mean producers/product like adopt
enzym estim penetr could add revenu
drive group organ growth per annum come year
grow confid corn inocul novozym expect achiev
sold acr corn inocul product fy ahead previous
expect acr show good take-up new product doubl
level furthermor yield benefit continu increas launch
estim price base yield
benefit farmer believ increas
yield improv demonstr estim add
group organ growth per annum
valuat risk valu novozym averag
price-to-earnings multipl ev/ebitda
multipl dcf wacc risk
invest case lower oil price impact market share
valuat metric
price month
price rel chart measur perform
omxc close
spot exchang rate
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
novozym a/ denmark-bas biotechnolog compani
engag product sale industri enzym
busi consist two segment enzym busi segment
price aug rate outperform target price analyst mathew hampshire-waugh
profit tax
associ
chang work capit
cash non-cash item
flow oper
free cash-flow firm
flow invest
issuanc retir debt
cash-flow financ
chang net cash/debt
return peak oil would gener organ growth
could justifi novozym rerat toward histor pe premium
return trough oil would gener organ growth could
justifi novozym derat toward low end histor pe
trade
price rel chart measur perform omxc
close
spot exchang rate
net debt start
chang net debt
net debt end
total equiti liabil
share wtd average mn
ratio valuat
net debt ebitda
downgrad forecast ebit forecast period organ growth larg
unchang divis chang follow
household reduc organ growth due
impact truck strike brazil/distribut issu henkel dont assum
issu materi impact howev assum novozym
recoup lost sale either forecast organ growth houshold fy
function roll hygein busi
manag good visabl
energi increas organ growth base
market share gain ethanol oil remain elev price custom
return novozym higher yield enzym solut novozym post growth
forecast tougher compar assum
annualis share gain seen
ag feed increas fy organ growth better
expect larg driven increas sale newli launch
corn inocul taken acreag sale drive
higher organ growth assum averag price corn product
price increas certifi yield
increas plant acr justifi higher share valu captur allianc
margin overal increas organ growth lower
forecast margin adjust report lower margin
function run-rat given product gain off-set fx higher raw
figur credit suiss earn forecast chang novozym
highlight month forward consensu ev/ebitda novozym trade
discount peer premium year averag vs peer
month forward consensu price-to-earnings novozym trade premium peer
premium year histor averag vs peer
rel
compani mention price
